Paladin Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Paladin Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.8K	Hold	400	–	–	0.01%	198
2026 Q1	$10.6K	Hold	400	–	–	0.01%	204
2025 Q4	$11.6K	Hold	400	–	–	0.01%	204
2025 Q3	$11.1K	Hold	400	–	–	0.01%	198
2025 Q2	$9.74K	Hold	400	–	–	0.01%	199
2025 Q1	$8.3K	Hold	400	–	–	0.01%	201
2024 Q4	$9.42K	Hold	400	–	–	0.01%	202
2024 Q3	$10.2K	Hold	400	–	–	0.01%	199
2024 Q2	$9.29K	Hold	400	–	–	0.01%	194
2024 Q1	$11.3K	Hold	400	–	–	0.01%	190
2023 Q4	$13.1K	Hold	400	–	–	0.01%	189
2023 Q3	$11.1K	Hold	400	–	–	0.01%	208
2023 Q2	$13.6K	Hold	400	–	–	0.01%	207
2023 Q1	$12K	Buy	+400	New	+$12.4K	0.01%	210
2022 Q2	–	Sell	-400	Closed	-$14K	–	300
2022 Q1	$19K	Buy	+400	New	+$19.1K	0.02%	213

Other funds holding ARKG

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

SFC

Strategic Financial Concepts San Antonio, Texas $336M AUM 22.98% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Paladin Advisory Group's ARKG Position: Q2 2026 in Review

Paladin Advisory Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 400 shares worth $16.8K. The position accounts for 0.01% of the portfolio, ranked #198.

Paladin Advisory Group first reported a position in ARKG in Q1 2022 and has held it in 15 quarters since. The position peaked at $19K in Q1 2022. 104 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Paladin Advisory Group held 400 shares of ARK Genomic Revolution ETF worth $16.8K as of Q2 2026.
Paladin Advisory Group left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of Paladin Advisory Group's portfolio in Q2 2026, its #198 holding.
Paladin Advisory Group first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 15 quarters since.
Paladin Advisory Group's ARK Genomic Revolution ETF position peaked at $19K in Q1 2022.
104 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Paladin Advisory Group's 13F filing for Q2 2026, filed 28 Jul 2026.